{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ1",
        "Protein_Change": {
          "ref": "E",
          "alt": "D",
          "position": "64"
        },
        "variant_string_id": "DJ1 E64D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the DJ1 gene were described as a cause of autosomal recessive EOPD (PARK7).",
          "judgment": "Yes",
          "reasoning": "The paper identifies DJ1 mutations as causative of autosomal recessive early-onset Parkinson's disease (EOPD), thus defining the disease mechanism in relation to the gene.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Immunocytochemistry and protein stability assays (Western blot) are used to assess changes in protein localization and expression levels.",
          "judgment": "Yes",
          "reasoning": "Immunocytochemistry (assessing protein localization) and protein stability assays are relevant to understanding the impact of DJ1 mutations on its function and contribution to EOPD, modeling protein function and stability which are applicable in the context of this disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "HEK293 cells were transiently transfected with wild-type or mutant DJ1, respectively...Lysate from untransfected HEK293 cells served as negative control.",
          "judgment": "Yes",
          "reasoning": "The study uses both normal/wild-type controls (wild-type DJ1 transfection) and negative/null controls (untransfected cells) and mentions replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "HEK293 cells transfected with cDNA encoding wild-type, D64, or P166 mutant DJ1-V5-His fusion protein produced a band of the expected size...After 48 hr of transfection, the mutant P166 DJI showed markedly decreased amounts of protein compared to wild-type DJ1 protein, confirming previous studies.",
          "judgment": "Yes",
          "reasoning": "The study used a known pathogenic variant (P166L) as a control, and this variant has been previously functionally characterized. Therefore, variant controls were used in the assay.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper provides qualitative assessments (e.g., 'markedly decreased amounts') but does not include quantitative statistical analyses or OddsPath calculations.",
          "judgment": "No",
          "reasoning": "The paper does not report specific statistical tests, p-values, confidence intervals, or OddsPath calculations for the functional data.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study uses P166L as a positive control. Thus, at least one pathogenic variant control was used.",
          "judgment": "Yes",
          "reasoning": "The number of pathogenic variant controls used in this study exceeds 10 or less: P166L is the only known pathogenic variant that was used.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E64D mutation shows decreased protein levels and altered cellular localization compared to wild-type DJ1, suggesting a loss-of-function effect. While the study includes relevant controls and replicates, the lack of statistical analysis limits the strength of the functional evidence to PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "DJ1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the DJ1 gene were described as a cause of autosomal recessive EOPD (PARK7).",
          "judgment": "Yes",
          "reasoning": "The paper identifies DJ1 mutations as causative of autosomal recessive early-onset Parkinson's disease (EOPD), thus defining the disease mechanism in relation to the gene.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Immunocytochemistry and protein stability assays (Western blot) are used to assess changes in protein localization and expression levels.",
          "judgment": "Yes",
          "reasoning": "Immunocytochemistry (assessing protein localization) and protein stability assays are relevant to understanding the impact of DJ1 mutations on its function and contribution to EOPD, modeling protein function and stability which are applicable in the context of this disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "HEK293 cells were transiently transfected with wild-type or mutant DJ1, respectively...Lysate from untransfected HEK293 cells served as negative control.",
          "judgment": "Yes",
          "reasoning": "The study uses both normal/wild-type controls (wild-type DJ1 transfection) and negative/null controls (untransfected cells) and mentions replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Independent lysate of HEK293 cells expressing wild-type DJ1-V5-His fusion protein was used as positive control",
          "judgment": "No",
          "reasoning": "No additional pathogenic or benign controls were tested.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "L166P displays markedly decreased amounts of protein. No additional controls were provided in the paper, therefore strength is PS3_supporting."
    }
  ]
}
